130 related articles for article (PubMed ID: 18991099)
1. Endothelin-1 does not change the function of monocyte-derived dendritic cells grown from patients with systemic sclerosis.
Slobodin G; Pavlotzky E; Panov J; Rosner I; Kessel A; Toubi E
Immunol Invest; 2008; 37(8):841-8. PubMed ID: 18991099
[TBL] [Abstract][Full Text] [Related]
2. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
3. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
4. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma endothelin-1 levels in patients with systemic sclerosis.
Yamane K; Miyauchi T; Suzuki N; Yuhara T; Akama T; Suzuki H; Kashiwagi H
J Rheumatol; 1992 Oct; 19(10):1566-71. PubMed ID: 1464869
[TBL] [Abstract][Full Text] [Related]
6. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
Mok MY; Cheung BM; Lo Y; Leung RY; Wong WS; Lau CS
J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
[TBL] [Abstract][Full Text] [Related]
8. Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran R; Azam A; Black C; Dashwood MR
J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis.
Peterlana D; Puccetti A; Caramaschi P; Biasi D; Beri R; Simeoni S; Corrocher R; Lunardi C
Scand J Rheumatol; 2006; 35(2):133-7. PubMed ID: 16641048
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.
Porciello G; Scarpato R; Ferri C; Storino F; Cagetti F; Morozzi G; Bellisai F; Migliore L; Marcolongo R; Galeazzi M
J Rheumatol; 2003 Jun; 30(6):1244-7. PubMed ID: 12784397
[TBL] [Abstract][Full Text] [Related]
11. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 secretion by alveolar macrophages in systemic sclerosis.
Odoux C; Crestani B; Lebrun G; Rolland C; Aubin P; Seta N; Kahn MF; Fiet J; Aubier M
Am J Respir Crit Care Med; 1997 Nov; 156(5):1429-35. PubMed ID: 9372656
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
15. Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.
Dziankowska-Bartkowiak B; Zalewska A; Sysa-Jedrzejowska A
Med Sci Monit; 2004 May; 10(5):CR202-8. PubMed ID: 15114270
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
17. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.
Wuttge DM; Wildt M; Geborek P; Wollheim FA; Scheja A; Akesson A
Arthritis Res Ther; 2007; 9(5):R85. PubMed ID: 17784951
[TBL] [Abstract][Full Text] [Related]
19. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
20. Prolactin synthesis by lymphocytes from patients with systemic sclerosis.
Czuwara-Ladykowska J; Sicinska J; Olszewska M; Uhrynowska-Tyszkiewicz I; Rudnicka L
Biomed Pharmacother; 2006 May; 60(4):152-5. PubMed ID: 16632298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
